<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350555</id>
  <title nil="true"/>
  <common-name>1-(4-chlorophenyl)-3-[2-[[4-[(z)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]benzimidazol-1-yl]propan-1-one</common-name>
  <description>1-(4-chlorophenyl)-3-[2-[[4-[(z)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]benzimidazol-1-yl]propan-1-one is a chemical compound with the formula C30H31ClN4O. It has an average molecular weight of 499.00 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>6912203</pubchem-id>
  <chemical-formula>C30H31ClN4O</chemical-formula>
  <weight>499</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T15:41:47Z</created-at>
  <updated-at type="dateTime">2026-08-31T15:41:47Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1CN(CCN1CC=CC2=CC=CC=C2)CC3=NC4=CC=CC=C4N3CCC(=O)C5=CC=C(C=C5)Cl</moldb-smiles>
  <moldb-formula>C30H31ClN4O</moldb-formula>
  <moldb-inchi>InChI=1S/C30H31ClN4O/c31-26-14-12-25(13-15-26)29(36)16-18-35-28-11-5-4-10-27(28)32-30(35)23-34-21-19-33(20-22-34)17-6-9-24-7-2-1-3-8-24/h1-15H,16-23H2/b9-6-</moldb-inchi>
  <moldb-inchikey>HBHDWQGSVARZJB-TWGQIWQCSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">498.2186393</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346448</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>1-(4-chlorophenyl)-3-[2-[[4-[(z)-3-phenylprop-2-enyl]piperazin-1-yl]methyl]benzimidazol-1-yl]propan-1-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic oxygen compounds</superklass>
  <klass>Organooxygen compounds</klass>
  <subklass>Carbonyl compounds</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0300860</sync-id>
  <structure-inchikey>HBHDWQGSVARZJB-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000000208000000000000000000000000000000000800000000000000000400000020000000004000020040000000000000000004000000000001000000000004000000000000000000000200000000002000000000000000000000180002100800010000000000a0000000000020100000000000000000000000000000000028000c04000000000004000000000000100000000000000000000040000000000000000480000084000000000020000100000008000010000000000000408000000000000200000000000000010044000000000000200040000010000020000000001000040000000008400000000000000000000000000804000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAKAAAAIABBgBgAAAAAgIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:33Z</structure-indexed-at>
</compound>
